All
South Beach Symposium Recap: Day 4
Catch up on coverage from the final day of South Beach Symposium.
Tirbanibulin Improves Skin in Patients with Actinic Keratosis
A poster presentation from SBS 2023 reviewed the clinician satisfaction of tirbanibulin for the treatment of actinic keratosis.
Analyzing the Gut-Skin-Brain Axis
Doris Day, MD, thoroughly discussed the up-and-coming topic of the gut-skin-brain axis related to healthy skin at SBS 2023.
Atopic Dermatitis Considerations With Peter Lio, MD
Lio shares key highlights of his atopic dermatitis sessions at South Beach Symposium.
Updates on Biologics and Atopic Dermatitis With Andrew Alexis, MD
Alexis shares take-home points from his popular sessions at South Beach Symposium.
South Beach Symposium Recap: Day 3
Catch up on coverage from the third day of South Beach Symposium.
Benzene Contamination and Boxed Warning Myths With Christopher Bunick, MD, PhD
SBS 2023 planning committee member, Christopher Bunick, MD, PhD, shares highlights from a few key sessions.
Acne and Rosace Updates at SBS 2023
Hilary Baldwin, MD, shares treatment updates and recommendations for acne and rosacea at South Beach Symposium.
Karan Lal, DO, FAAD, Discusses Highlights from SBS and MOPDS
The Masters of Pediatric Dermatology Symposium at SBS 2023 covered current trends and updates in pediatric dermatology.
New Innovations in Genomics
Aaron Farberg, MD, FAAD, discussed updates and applications of genomics in dermatology at South Beach Symposium.
What’s Trending in Body Rejuvenation?
Suneel Chilukuri, MD, presented top trending topics in body rejuvenation at SBS 2023.
New Positive Phase 3 Data of Delgocitinib for Chronic Hand Eczema
Chronic hand eczema can have a significant negative impact on quality of life.
South Beach Symposium Recap: Day 2
Catch up on coverage from the second day of South Beach Symposium.
Hyperpigmentation With Suneel Chilukuri, MD
Chilukuri shares pearls from his hyperpigmentation session at SBS 2023.
Results of Phase 2 Study Evaluating Hidradenitis Suppurativa Drug Announced
Incyte announces that its study of povorcitinib revealed sustained and durable efficacy after 1 year.
Healthy Skin Barrier for Xerosis in Mature Skin
The development of xerosis in mature skin was analyzed in a poster presentation from SBS 2023.
Aesthetic Procedures for LGBTQ+ Patients
Ronda Farah, MD, gave an in-depth overview of aesthetic procedures to understand for LGBTQ+ patients at SBS 2023.
Artificial Intelligence and Skin Cancer
Laura Ferris, MD, PhD, discusses the future landscape of artificial intelligence and skin cancer detection at SBS 2023.
Glynis Ablon, MD, FAAD, Discusses Filler Complications and Exosomes
Ablon’s sessions at SBS 2023 covered filler complications and the future of exosomes.
South Beach Symposium Recap: Day 1
Catch up on coverage from the first day of South Beach Symposium.
Increasing Rates of Melanoma and What to Look For
David Goldberg, MD, JD, explores the increasing rates of melanoma in the US and how to manage melanoma subtypes at SBS 2023.
Psychosocial and Social Media Impact on Adolescent Skin Disease and Mental Health
A poster presentation from SBS 2023 analyzed the relationship between dermatology and social media.
Visiting the Sunshine State: What to do While Attending SBS
Discover fun activities to explore while attending South Beach Symposium 2023.
Aaron Farberg, MD, FAAD, Discusses Hedgehog Inhibitors at SBS
Farberg shares key pearls from his session on when to use hedgehog inhibitors at South Beach Symposium 2023.
What to Expect at the 2023 South Beach Symposium Meeting
The 2023 South Beach Symposium meeting begins today in Miami Beach, Florida.
Pointers With Portela: Men's Health
In this week’s Pointers with Dr Portela, the 208SkinDoc interviews Benjamin Bashline, DO, to discuss men's health.
Equity Indexed Life Insurance Policies and Structured Notes: Asset Classes With Principal Protection and Growth Potential
This article reviews equity-indexed life insurance policies and structured notes, instruments that offer investment protection and growth potential.
It's Unlikely that Humira Biosimilars Will Drive Down Drug Costs
As a dozen Humira Biosimilars are set to enter the market this year, it seems to be unlikely that they will drive down drug costs in the future.
The Mainstream Patient: February 7
This week's edition of the Mainstream Patient features stories about recommended razors for keratosis pilaris, dermatologist-recommended retinol serums, how to patch test skin care products, and more.
Merkel Cell Polyomavirus and Associated Merkel Cell Carcinoma
Merkel cell carcinoma is a rare but highly aggressive type of nonmelanoma skin cancer and Merkel cell polyomavirus is thought to play a major role in its etiology.
